IGM Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
IGM Biosciences has a total shareholder equity of $161.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $376.1M and $214.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$293.77m |
Equity | US$161.25m |
Total liabilities | US$214.88m |
Total assets | US$376.13m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1K0's short term assets ($302.8M) exceed its short term liabilities ($37.9M).
Long Term Liabilities: 1K0's short term assets ($302.8M) exceed its long term liabilities ($176.9M).
Debt to Equity History and Analysis
Debt Level: 1K0 is debt free.
Reducing Debt: 1K0 currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1K0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1K0 has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 28.5% each year.